AbbVie Statistics

Total Valuation

AbbVie has a market cap or net worth of CAD 445.94 billion. The enterprise value is 538.03 billion.

Market Cap	445.94B
Enterprise Value	538.03B

Important Dates

The next estimated earnings date is Friday, January 31, 2025.

Earnings Date	Jan 31, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.07%
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.76B

Valuation Ratios

The trailing PE ratio is 64.97.

PE Ratio	64.97
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.43, with an EV/FCF ratio of 25.49.

EV / Earnings	78.38
EV / Sales	6.74
EV / EBITDA	14.43
EV / EBIT	21.68
EV / FCF	25.49

Financial Position

The company has a current ratio of 0.65, with a Debt / Equity ratio of 11.75.

Current Ratio	0.65
Quick Ratio	0.44
Debt / Equity	11.75
Debt / EBITDA	2.75
Debt / FCF	4.57
Interest Coverage	6.47

Financial Efficiency

Return on equity (ROE) is 56.41% and return on invested capital (ROIC) is 14.32%.

Return on Equity (ROE)	56.41%
Return on Assets (ROA)	7.72%
Return on Capital (ROIC)	14.32%
Revenue Per Employee	1.50M
Profits Per Employee	137,284
Employee Count	50,000
Asset Turnover	0.40
Inventory Turnover	3.91

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +10.87% in the last 52 weeks. The beta is 0.62, so AbbVie's price volatility has been lower than the market average.

Beta (5Y)	0.62
52-Week Price Change	+10.87%
50-Day Moving Average	26.46
200-Day Moving Average	26.00
Relative Strength Index (RSI)	46.62
Average Volume (20 Days)	12,293

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.10

Income Statement

In the last 12 months, AbbVie had revenue of CAD 75.02 billion and earned 6.86 billion in profits. Earnings per share was 3.88.

Revenue	75.02B
Gross Profit	52.77B
Operating Income	23.33B
Pretax Income	9.72B
Net Income	6.86B
EBITDA	34.62B
EBIT	23.33B
Earnings Per Share (EPS)	3.88

Full Income Statement

Balance Sheet

The company has 9.84 billion in cash and 96.35 billion in debt, giving a net cash position of -86.51 billion.

Cash & Cash Equivalents	9.84B
Total Debt	96.35B
Net Cash	-86.51B
Net Cash Per Share	n/a
Equity (Book Value)	8.20B
Book Value Per Share	4.61
Working Capital	-20.64B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 22.31 billion and capital expenditures -1.20 billion, giving a free cash flow of 21.11 billion.

Operating Cash Flow	22.31B
Capital Expenditures	-1.20B
Free Cash Flow	21.11B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 70.33%, with operating and profit margins of 31.10% and 9.22%.

Gross Margin	70.33%
Operating Margin	31.10%
Pretax Margin	12.96%
Profit Margin	9.22%
EBITDA Margin	46.15%
EBIT Margin	31.10%
FCF Margin	28.13%

Dividends & Yields

AbbVie does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	212.79%
Buyback Yield	0.07%
Shareholder Yield	0.07%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AbbVie has an Altman Z-Score of 1.9. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.9
Piotroski F-Score	n/a